Advertisements



Gemphire Therapeutics" stock extends slide, plummets 39% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics stock tumbles 17% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Spark Therapeutics stock plummets 28% premarket on hemophilia trial"s patient safety concerns

Spark Ther.....»»

Category: topSource: marketwatchAug 7th, 2018

Spark Therapeutics stock plummets 25% premarket on hemophilia trial"s patient safety concerns

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 7th, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Flex Pharma"s stock extends slide, plunges 67% premarket after ending phase 2 trial, cutting jobs

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 13th, 2018

Adient"s stock extends slide, plunges 12% premarket after preliminary Q1 results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJan 16th, 2019

Macy"s stock extends slide, tumbles 18% premarket after earnings and sales outlook cut

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJan 10th, 2019

Canopy Growth"s stock extends slide, falls 10% premarket after Q2 results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchNov 14th, 2018

Royal Caribbean"s stock extends slide, falls 2.8% premarket after Q3 results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 25th, 2018

Mirati Therapeutics stock drops 30% premarket after cancer trial results

Mirati Therapeutics Inc. shares dropped 30% in Monday premarket trade after the company presented results from a phase 2 trial in which its cancer drug sitravatinib was combined with Bristol-Myers Squibb Co.'s cancer drug Opdivo . The trial enrolled p.....»»

Category: topSource: marketwatchOct 22nd, 2018

Proteostasis Therapeutics" stock more than triples after positive trial results

Shares of Proteostasis Therapeutics Inc. more than tripled (up 207%) in premarket trade on heavy volume, after the biopharmaceutical company announced positive results from .....»»

Category: topSource: marketwatchOct 18th, 2018

Walgreens" stock extends slide, drops 4.7% premarket after Q4 results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 11th, 2018

Viking Therapeutics stock jumps 4.8% premarket on news of positive trial results

Viking Therapeutics Inc. shares surged x% in premarket trade Monday, after the company reported positive results in a mid-stage trial of a treatment for broken hips. The company said its Phase 2 trial of VK5.....»»

Category: topSource: marketwatchOct 1st, 2018

Alderya"s stock rockets after positive trial results of mesothelioma treatment

Shares of Aldeyra Therapeutics Inc. rocketed 35% toward a record high in active premarket trade Wednesday, after the biotechnology company announced positive results from a phase 1/2 trial of its treatment for pleural m.....»»

Category: topSource: marketwatchSep 26th, 2018

Galectin stock lifts 15% premarket on early cancer combination trial results

Galectin Therapeutics Inc. shares surged 15% in Thursday premarket trade after the company said that combining its therapy, GR-MD-02, with Key.....»»

Category: topSource: marketwatchSep 20th, 2018

UPDATE: Viking Therapeutics stock rockets 140% after positive trial of non-alcoholic fatty liver treatment

Viking Therapeutics Inc. stock rocketed 140% in premarket trade Tuesday, after the company reported positive results in a mid-stage tr.....»»

Category: topSource: marketwatchSep 18th, 2018

Viking Therapeutics stock rockets 140% premarket as trading resumes after halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 18th, 2018

Tesla"s stock extends slide, tumbled 7.7% premarket toward a 5-mo. low

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 7th, 2018

Sangamo stock drops 13% premarket on results of phase 1/2 gene editing trial

Sangamo Therapeutics Inc. shares dropped 13% in Wednesday premarket trade after the company released results for a phase 1/2 trial of its gene editing candidate SB-913, which is intended for the .....»»

Category: topSource: marketwatchSep 5th, 2018

Gemphire Therapeutics stock plunges after trial halted due to "unanticipated problems"

Shares of Gemphire Therapeutics Inc. plunged 17% toward a record low F.....»»

Category: topSource: marketwatchAug 10th, 2018